A study prospectively evaluating a stratified approach to selecting treatment heralds a new era of precision medicine for type 2 diabetes, which should incorporate ongoing discovery, social determinants of health and healthcare transformation.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Philipson, L. H. Nat. Rev. Endocrinol. 16, 79–80 (2020).
Davies, M. J. et al. Diabetes Care 45, 2753–2786 (2022).
Shields, B. M. et al. Nat. Med. https://doi.org/10.1038/s41591-022-02120-7 (2022).
Shields, B. M. et al. Nat. Med. https://doi.org/10.1038/s41591-022-02121-6 (2022).
Brankovic, M. et al. Eur. J. Clin. Invest. 49, e13145 (2019).
Schernthaner, G. et al. Diabetes Care 36, 2508–2515 (2013).
Neuen, B. L. et al. Lancet Diabetes Endocrinol. 7, 845–854 (2019).
Zinman, B. et al. Diabetes Care 41, 1783–1791 (2018).
Inzucchi, S. E. et al. Diabetes Care 41, 356–363 (2018).
Buse, J. B. et al. Diabetes Care 43, 1546–1552 (2020).
Frías, J. P. et al. N. Engl. J. Med. 385, 503–515 (2021).
Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: a New Health System for the 21st Century (National Academies Press, 2001).
Duan, N., Kravitz, R. L. & Schmid, C. H. J. Clin. Epidemiol. 66, S21–S28 (2013).
S.J.P. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K23DK128572). N.M.M. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK126825).
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Pilla, S.J., Mathioudakis, N.N. & Maruthur, N.M. Trialing precision medicine for type 2 diabetes. Nat Med 29, 309–310 (2023). https://doi.org/10.1038/s41591-022-02168-5